Cypress Capital Management (Wyoming)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cypress Capital Management (Wyoming)'s BMY Position: Q3 2019 in Review
Cypress Capital Management (Wyoming) sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 660 shares — an estimated $30K sold.
Cypress Capital Management (Wyoming) first reported a position in BMY in Q4 2014 and held it in 19 quarters. The position peaked at $1.22M in Q2 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.
- Cypress Capital Management (Wyoming) reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
- Cypress Capital Management (Wyoming) sold 660 Bristol-Myers Squibb shares in Q3 2019, an estimated $30K.
- Cypress Capital Management (Wyoming) first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 19 quarters.
- Cypress Capital Management (Wyoming)'s Bristol-Myers Squibb position peaked at $1.22M in Q2 2016.
- 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.
Based on Cypress Capital Management (Wyoming)'s 13F filing for Q3 2019, filed 12 Nov 2019.